Global Adalimumab Tenders and GPN from across the Globe

Acquisition of Ada, Eca and Infliximab and Adalimumab Reagents, with Equipment Placement (2025-2028)

Delivery of Medicinal Products with Lease of Devices, Entertaining and Parenteral Nutrition for Use for the Needs of the Municipal Hospital in Siemianowice Śląskie Sp. Z O.O.

Inj. Adalimumab 40 Mg 0.8 Ml Pfs

Inj Adalimumab 40 mg, Qty: 6 Vial, (BOQ Item #3)

Inj Adalimumab 40 mg, Qty: 60 Vial, (BOQ Item #37)

Inj Adalimumab 40 mg, Qty: 2 PFS, (BOQ Item #110)

Inj. Adalimumab 40 Mg Per 0.8 Ml

Adalimumab 40 mg Inj, Qty: 12 No, (BOQ Item #24)

Inj Adalimumab 40 Mg / 0.8 Ml, Qty: 14

Lp Containing Adalimumab 2025